bcl‐2, a novel reguator of cell death

BioEssays

Volumn 17, Issue 7, 1995, Pages 631-638

  Hockenbery, David M ^a  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTO ONCOGENE PROTEINS; PROTO ONCOGENE PROTEINS C BCL 2;

AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; CELL CYCLE; DRUG EFFECT; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CONSERVED SEQUENCE; HUMAN; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T;

EID: 0029328602     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.950170709     Document Type: Review

References (72)

1. Involvement of the bcl‐2 gene in human follicular lymphoma
2. H on chromosome 14 and near a transcriptional unit on chromosome 18
3. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint‐cluster region near a transcriptionally active locus on chromosome 18
4. Bcl‐2 gene promotes haemopoietic cell survival and cooperates with c‐myc to immortalize pre‐Bcells
5. Bcl‐2 is an inner mitochondrial membrane protein that blocks programmed cell death
6. Bcl‐2 and the regulation of programmed cell death
7. Prevention of programmed cell death in Caenorhabditis elegans by human bcl‐2
8. Apoptosis: a basic biologic phenomenon with wide‐ranging implications in tissue kinetics
9. C. elegans cell survival gene ced‐9 encodes a functional homolog of the mammalian proto‐oncogene bcl‐2
10. Bcl‐2 initiates a new category of oncogenes: regulators of cell death
11. A negative regulatory element in the bcl‐2 5′‐untranslated region inhibits expression from an upstream promoter
12. Identification of a p53‐dependent negative response element in the bcl‐2 gene
13. Ultrastructural localization of Bcl‐2 protein
14. Investigation of the subcellular distribution of the bcl‐2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
15. Targeting of bcl‐2 to the mitochondrial outer membrane by a COOH‐terminal signal anchor sequence
16. Role of membrane anchor domain of bcl‐2 in suppression of apoptosis caused by E1B‐defective adenovirus
17. Bcl‐2 associates with the ras‐related protein R‐ras p23
18. BCL2 protein is topographically restricted in tissues characterized by apoptotic death
19. Bcl‐2 protein expression is widespread in the developing nervous system and retained in the adult PNS
20. Bcl‐2 proto‐oncogene expression in normal and neoplastic human myeloid cells
21. Bcl‐2 protein expression during murine development
22. Molecular regulation of apoptosis: genetic controls on cell death
23. BH1 and BH2 domains of bcl‐2 are required for inhibition of apoptosis and heterodimerization with bax
24. Bcl‐2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
25. bcl‐x, a bcl‐2‐related gene that functions as a dominant regulator of apoptotic cell death
26. MCL 1, a gene expressed in programmed myeloid differentiation, has sequence similarity to BCL2
27. Interactions among members of the Bcl‐2 protein family analyzed with a yeast two‐hybrid system
28. Bcl‐2 functions in an antioxidant pathway to prevent apoptosis
29. Bcl‐2 inhibition of neural death: decreased generation of reactive oxygen species
30. Oxidative stress as a mediator of apoptosis
31. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
32. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin‐1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation
33. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T cell line in serum‐free media
34. bcl‐2 inhibits death of central neural cells induced by multiple agents
35. Genetic control of programmed cell death in the nematode Caenorhabditis elegans
36. The C. elegans cell death gene ced‐3 encodes a protein similar to mammalian interleukin‐1b‐converting enzyme
37. A novel heterodimeric cysteine protease is required for interleukin‐1b processing in monocytes
38. Molecular cloning of the interleukin‐1b converting enzyme
39. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins
40. Human cytotoxic lymphocyte granzyme B
41. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells
42. Induction of apoptosis in fibroblasts by IL‐1b‐converting enzyme, a mammalian homolog of the C. elegans cell death gene ced‐3
43. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced‐3 and the mammalian IL‐1b‐converting enzyme
44. Lch‐1, an lce/ced‐3‐related gene, encodes both positive and negative regulators of programmed cell death
45. Death by suicide: one way to go in mammalian cellular development?
46. Nuclear events of apoptosis in vitro in cell‐free mitotic extracts: a model system for analysis of the active phase of apoptosis
47. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes
48. cdc2 activation required for apoptosis
49. Activation of cyclin A‐dependent protein kinases during apoptosis
50. Cdc2 activation is not required for thymocyte apoptosis
51. Growth factor starvation of bcl‐2 overexpressing murine bone marrow cells induced refractoriness to IL‐3 stimulation of proliferation
52. c‐myc and bcl‐2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle
53. Programmed cell death and the control of cell survival: lessons from the nervous sys tem
54. Prevention of vertebrate neuronal death by the crmA gene
55. Induction of apoptosis in fibroblasts by c‐myc protein
56. Continuous c‐fos expression precedes programmed cell death in vivo
57. High levels of c‐rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro
58. p53 and E2F‐1 cooperate to mediate apoptosis
59. The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max
60. Expression of bcl‐2 in fetal tissues suggests a role in morphogenesis
61. Regulation of bcl‐2 proto‐oncogene expression during normal human lymphocyte proliferation
62. Characterization of A1, a novel hemopoietic‐specific early‐response gene with sequence similarity to bcl‐2
63. Tumour necrosis factor‐induced cytotoxicity is accompanied by intracellular mitogenic signals in ME‐180 human cervical carcinoma cells
64. Susceptibility to cytotoxic T lymphocyte‐induced apoptosis is a function of the proliferation status of the target
65. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors
66. Analysis of susceptibility of mature T lymphocytes to dexamethasone‐induced apoptosis
67. Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis
68. Bcl‐2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
69. Fulminant metanephric apoptosis and abnormal kidney development in bcl‐2‐deficient mice
70. Oncogenes and cell death
71. Bcl‐2 expression promotes B‐ but not T‐lymphoid development in SCID mice
72. + stage during positive selection and promotes differentiation at several control points